α7 Nicotinic Acetylcholine Receptor Mediated Neuroprotection in Parkinson’s Disease

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|13|5|623-630

ISSN： 1389-4501

Source： Current Drug Targets, Vol.13, Iss.5, 2012-05, pp. : 623-630

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Stress and the α7 Nicotinic Acetylcholine Receptor

By  

Current Drug Targets, Vol. 13, Iss. 5, 2012-05 ,pp. : 607-612

Bentham Science Publishers

Access to resources Recommend Favorite

Role of α7-Nicotinic Acetylcholine Receptor in Normal and Cancer Stem Cells

By  

Current Drug Targets, Vol. 13, Iss. 5, 2012-05 ,pp. : 356-365

Bentham Science Publishers

Access to resources Recommend Favorite

α7 Nicotinic Acetylcholine Receptor Subunit in Angiogenesis and Epithelial to Mesenchymal Transition

By  

Current Drug Targets, Vol. 13, Iss. 5, 2012-05 ,pp. : 671-679

Bentham Science Publishers

Access to resources Recommend Favorite

7 Nicotinic Acetylcholine Receptor as a Potential Therapeutic Target for Schizophrenia

By  

Current Pharmaceutical Design, Vol. 17, Iss. 2, 2011-01 ,pp. : 121-129

Bentham Science Publishers

Access to resources Recommend Favorite

Role of ?7-Nicotinic Acetylcholine Receptor in Normal and Cancer Stem Cells

By  

Current Drug Targets, Vol. 13, Iss. 5, 2012-04 ,pp. : 656-665

Bentham Science Publishers

Access to resources Recommend Favorite